Non-cancer Drugs Shine in Israel’s List of New Meds in Subsidized 'Health Basket'

The health-basket committee has also ramped up its criticism of companies demanding high prices

comments Print
More than 100 new drugs and technologies – at a cost of 460 million shekels ($133 million) – will be added to Israel’s “health basket” of subsidized treatments next year, though cancer products will make up...